Jefferies maintains a cautious 'Hold' on Fortinet ahead of its earnings, forecasting a modest Q4 beat but expressing concerns over lofty expectations embedded in 2026 estimates for the cybersecurity firm.
As a cornerstone of Warren Buffett's portfolio, Coca-Cola's powerful brand and reliable dividends offer stability. Yet, its mature global footprint suggests investors seeking explosive growth should look elsewhere.
IT solutions giant CDW (NASDAQ:CDW) reported stronger-than-expected fourth-quarter results for 2025, with revenue rising 6.3% to $5.51 billion and adjusted EPS of $2.57 surpassing forecasts. The performance underscores resilient corporate IT spending despite broader economic uncertainties.
Life sciences firm Azenta (AZTA) edged past Wall Street's revenue expectations for its fiscal fourth quarter, though year-over-year sales remained stagnant. While adjusted earnings met consensus, the company's long-term growth trajectory and path to sustained profitability remain key investor concerns.
Morgan Stanley downgraded NetApp (NTAP) and slashed its price target, pointing to a CIO survey revealing the weakest hardware budget growth in 15 years. The move contrasts with a recent bullish initiation from Goldman Sachs.
Despite reporting robust quarterly earnings and record assets under custody, State Street sees key price targets trimmed by analysts who flag rising costs and a lack of updated medium-term guidance.
A key restructuring deal for Ethiopia's sole international bond has been blocked by an official creditor committee, prompting threats of legal action from investors and casting new uncertainty over the country's debt resolution process.
TD Cowen reiterates a Buy rating on Incyte (INCY), significantly raising its price target to $128, citing the company's detailed strategy to triple revenue outside its flagship drug Jakafi by the end of the decade.
Cantor Fitzgerald and Wells Fargo have raised their price targets on The Hartford following better-than-expected fourth-quarter results, citing disciplined expense management and a resilient growth trajectory despite sector headwinds.
Investment firm Cantor Fitzgerald has revised its price target for Qualcomm (QCOM) downward, reflecting concerns over conservative guidance and evolving competitive pressures in the smartphone chipset market.
As Bitcoin retreated toward $73,000, Cathie Wood's ARK Invest executed a strategic buying spree across six key crypto-linked equities, signaling continued conviction in the sector's long-term prospects despite recent volatility.
As Bitcoin stabilizes near $76,000, market analysts are looking beyond macroeconomics to investor psychology. Could deep-seated cognitive biases like anchoring and regret aversion be the hidden catalysts for the next major price move?
Financial firm Rothschild & Co. Redburn has downgraded PayPal Holdings Inc. (PYPL) from Neutral to Sell, slashing its price target to $50, citing concerns over eroding market share in the face of aggressive competition from newer payment platforms.
The US Congress has passed a one-year extension of the African Growth and Opportunity Act, a temporary reprieve for a cornerstone trade policy that has shaped US-Africa economic relations for over two decades, but the short-term renewal leaves exporters and investors wary.
Diamond Hill Capital's Small Cap Strategy added Centerspace (CSR) to its portfolio in Q4 2025, highlighting a focus on resilient real estate assets. The REIT's performance and future potential are analyzed against a backdrop of mixed market gains and ongoing economic uncertainty.
Manufacturing giant Flex (NASDAQ: FLEX) delivered a robust fourth-quarter performance for CY2025, surpassing revenue and profit expectations. The company's results highlight the resilience of its diversified industrial portfolio amid a complex global economic landscape.
Following the October 2025 flash crash and ongoing regulatory pressures, confidence in Binance has wavered, prompting significant capital outflows. We examine the fallout and explore three established alternatives for traders seeking stability.
Despite posting strong fourth-quarter results that beat estimates, Boston Scientific's shares fell sharply after the medical device giant provided a 2026 revenue and profit outlook that fell short of Wall Street's expectations, raising questions about growth following its major acquisition.
AbbVie (NYSE: ABBV) reported fourth-quarter 2025 revenue of $16.62 billion, a 10% year-over-year increase that surpassed Wall Street forecasts. Adjusted earnings per share of $2.71 also topped consensus estimates, signaling resilience in its growth strategy.
Nintendo's stock tumbled over 11% as quarterly earnings revealed pressure from rising component costs and thinner margins on its new console, even as Switch 2 sales exceeded expectations.
